Add to ORKGSlide 5-14: Resistance to B16 melanoma, following injection of CD1d-B16/GalCer i.v., requires CD4+ and CD8+ cellshttps://digitalcommons.rockefeller.edu/nkt-cells/1013/thumbnail.jp
Checkpoint inhibitors act by blocking physiologic mechanisms coopted by tumor cells to evade immune ...
CD63 has been identified in human melanoma cells by a number of different monoclonal antibodies (MAb...
Side population (SP) is identified as cells capable of excluding the fluorescent Hoechst dye and ant...
Slide 5-14: B16 melanoma cells, coated with α-Galactosyl ceramide and injected intravenously, allow ...
Slide 5-15: A single dose of B16 melanoma cells, coated with α-Galactosyl ceramide and injected I.V....
B16 melanoma loaded with α-Galactosyl ceramide, elicit T cell-independent innate resistance to metas...
Slide 5-12: B16 and CD1d-Transfected B16 Melanoma are tumorigenic via the subcutaneous routehttps://...
Slide 5-23: B16/GalCer Tumor Cells, injected I. V., induce IL 12 formation by CD8+ dendritic cells v...
Slide 5-22: B16/GalCer tumor cells, injected I.V., rapidly mature dendritic cells in an NKT cell-dep...
It has been shown that a side population (SP), which is characterized by high chemical efflux capaci...
In melanoma, therapies with inhibitors to oncogenic BRAFV600E are highly effective but responses are...
The development of cellular resistance to immunotoxins has been demonstrated in a variety of models ...
Innate resistance to several transplantable tumors loaded with α-Galactosyl ceramidehttps://digitalc...
grantor: University of TorontoHuman cutaneous melanoma sometimes may progress through wel...
Autologous vaccination with tumor-primed dendritic cells increases immune response against tumor, wh...
Checkpoint inhibitors act by blocking physiologic mechanisms coopted by tumor cells to evade immune ...
CD63 has been identified in human melanoma cells by a number of different monoclonal antibodies (MAb...
Side population (SP) is identified as cells capable of excluding the fluorescent Hoechst dye and ant...
Slide 5-14: B16 melanoma cells, coated with α-Galactosyl ceramide and injected intravenously, allow ...
Slide 5-15: A single dose of B16 melanoma cells, coated with α-Galactosyl ceramide and injected I.V....
B16 melanoma loaded with α-Galactosyl ceramide, elicit T cell-independent innate resistance to metas...
Slide 5-12: B16 and CD1d-Transfected B16 Melanoma are tumorigenic via the subcutaneous routehttps://...
Slide 5-23: B16/GalCer Tumor Cells, injected I. V., induce IL 12 formation by CD8+ dendritic cells v...
Slide 5-22: B16/GalCer tumor cells, injected I.V., rapidly mature dendritic cells in an NKT cell-dep...
It has been shown that a side population (SP), which is characterized by high chemical efflux capaci...
In melanoma, therapies with inhibitors to oncogenic BRAFV600E are highly effective but responses are...
The development of cellular resistance to immunotoxins has been demonstrated in a variety of models ...
Innate resistance to several transplantable tumors loaded with α-Galactosyl ceramidehttps://digitalc...
grantor: University of TorontoHuman cutaneous melanoma sometimes may progress through wel...
Autologous vaccination with tumor-primed dendritic cells increases immune response against tumor, wh...
Checkpoint inhibitors act by blocking physiologic mechanisms coopted by tumor cells to evade immune ...
CD63 has been identified in human melanoma cells by a number of different monoclonal antibodies (MAb...
Side population (SP) is identified as cells capable of excluding the fluorescent Hoechst dye and ant...